Relationship between serum prostate-specific antigen and age in cadavers

被引:4
|
作者
Tsuboi, Hajime [1 ]
Miyamori, Daisuke [2 ]
Ishikawa, Noboru [3 ]
Ichioka, Hiroaki [1 ]
Ikegaya, Hiroshi [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Forens Med, 465 Kajiicho, Kyoto 6028566, Japan
[2] Hiroshima Univ, Grad Sch Med Sci, Dept Gen Med, Hiroshima, Japan
[3] Tokyo Dent Coll, Dept Histol & Dev Biol, Chiyoda Ku, Tokyo, Japan
来源
SAGE OPEN MEDICINE | 2020年 / 8卷
关键词
Prostate-specific antigen; age estimation; unidentified cadavers; BODY-MASS INDEX; CLINICAL-PERFORMANCE; HEALTH INDEX; MEN; PSA; CANCER; VALUES;
D O I
10.1177/2050312120958212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: An increase in number of unidentified cadavers is a growing problem. To identify these cadavers, a simple objective method is required to estimate cadaveric age. We examined the correlations between postmortem serum prostate-specific antigen levels and cadaveric age to determine whether serum prostate-specific antigen levels can be used in age estimation of unidentified cadavers. Methods: Total serum prostate-specific antigen was measured in 140 male autopsy cases aged from 0 to 94 years. Results: The serum prostate-specific antigen levels of cadavers correlated with age at death to the same degree as with the age of living individuals (r = 0.393,P < 0.01). Prostate-specific antigen levels also correlated with prostate weight, but not with psoas muscle index and body mass index. Cause of death did not influence postmortem serum prostate-specific antigen levels. Conclusion: Age estimation based on prostate-specific antigen provides a simple, objective, and rapid method to determine age at death estimation of cadavers, and is expected to greatly contribute to the identification of cadavers.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Relationship of prostate-specific antigen levels to prostate volume and age in mass screening subjects
    Akimoto, S
    Ichikawa, T
    Ito, H
    UROLOGIA INTERNATIONALIS, 1998, 60 (04) : 216 - 219
  • [42] Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
    Vickers, Andrew J.
    Sjoberg, Daniel D.
    Ulmert, David
    Vertosick, Emily
    Roobol, Monique J.
    Thompson, Ian
    Heijnsdijk, Eveline A. M.
    De Koning, Harry
    Atoria-Swartz, Coral
    Scardino, Peter T.
    Lilja, Hans
    BMC MEDICINE, 2014, 12
  • [43] Age-specific reference ranges of serum prostate-specific antigen in Iraqi men
    Hailan, Marwan
    Rifat, Usama Nihad
    ARAB JOURNAL OF UROLOGY, 2011, 9 (04) : 273 - 277
  • [44] POTENTIAL EFFECTS OF AGE-SPECIFIC REFERENCE RANGES FOR SERUM PROSTATE-SPECIFIC ANTIGEN
    LANKFORD, SP
    PETERS, KL
    ELSER, RC
    EUROPEAN UROLOGY, 1995, 27 (03) : 182 - 186
  • [45] Prostate-specific antigen for treatment monitoring
    Graefen, M.
    Froehner, M.
    Wirth, M.
    UROLOGE, 2011, 50 (03): : 309 - +
  • [46] Prostate-specific antigen immunoassays on the BioCD
    Wang, Xuefeng
    Zhao, Ming
    Nolte, David D.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2009, 393 (04) : 1151 - 1156
  • [47] Is the era of prostate-specific antigen over?
    Djavan, Bob
    Rocco, Bernardo
    Stangelberger, Anton
    De Cobelli, Ottavio
    Marberger, Michael
    BJU INTERNATIONAL, 2007, 100 : 8 - 10
  • [48] The association of pathogenic factors of metabolic syndrome on serum prostate-specific antigen levels: a pilot study
    Xia, Bo-Wen
    Zhao, Si-Cong
    Chen, Zong-Ping
    Chen, Chao
    Liu, Tian-Shu
    Yang, Fan
    Yan, Yong
    BMC UROLOGY, 2019, 19 (01)
  • [49] Age-specific prostate-specific antigen: A reassessment
    Etzioni, R
    Shen, Y
    Petteway, JC
    Brawer, MK
    PROSTATE, 1996, : 70 - 77
  • [50] Serum prostate-specific antigen in pancreatic disease
    Pezzilli, R
    Bertaccini, A
    Billi, P
    Zanarini, L
    Miglio, F
    Martorana, G
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (07): : 580 - 583